PeptideScanner retained ClinicalTrials.gov record NCT05506319 at 2026-11-15T22:08:31.832Z. Its registry update date was 2025-03-14, and PeptideScanner's reviewed identity mapping was vasopressin. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1